Most cancers Analysis UK says some sufferers with uncommon cancers are struggling to get entry to experimental medicine even when their docs wish to use them.
The organisation stated extra individuals had been searching for personal care. Our Well being Editor Hugh Pym has been talking to at least one affected person whose personal insurer won’t pay for a drug which could assist her.
AXA PPP Healthcare has stated that the drug in query just isn’t licensed or authorized by NICE (Nationwide Institute for Well being and Care Excellence). The corporate added that it was persevering with to fund different therapy.
Produced by Dominic Hurst. Video Journalist Harriet Bradshaw